- Measurements
- Waist circumference and blood pressure.
- Blood tests
- Glucose and lipids when appropriate.
- History
- Medicines, tobacco and family history.
On this page
A growing waistline, changes in blood sugar and less reliable erections can turn up around the same time. They may share a cause or have developed independently. When assessing erectile problems, it can help to consider how abdominal fat, insulin resistance, diabetes and blood vessel health fit together.
However, it cannot be said that every man with fat around the belly has testosterone deficiency or that insulin resistance explains all erection problems.
Fat around the waist
The subcutaneous fat tissue in the abdominal area and the visceral fat around the internal organs do not have the same characteristics. Increased visceral fat may contribute to changes associated with adipokine balance, fatty acid metabolism, and low-grade inflammation in some individuals.
Body mass index alone does not indicate fat distribution. Waist circumference, waist-to-height ratio and clinical risk factors should be evaluated together. Waist circumference thresholds used for metabolic syndrome vary by ethnic group and diagnostic system. For men of European origin, some criteria use the 94 cm limit, while other definitions may indicate 102 cm. These values are not the same definitive diagnostic limit for all societies.
Insulin resistance and erections
In insulin resistance, the response of muscle, liver and fat tissue to insulin may decrease. Initially, increased insulin secretion by the pancreas can keep blood glucose within normal limits. Therefore, the presence of normal glucose does not exclude insulin resistance in all cases.
Erection is a process related to the vascular endothelium and nitric oxide signaling in the penis. Dyslipidemia, hypertension and hyperglycemia accompanying insulin resistance may affect vascular functions. However, this connection alone does not prove that erectile dysfunction is of vascular origin.
The EAU 2026 Erectile Dysfunction Guidelines recommend that glucose and lipid profiles be evaluated in appropriate patients. Hormonal, neurological, psychological and drug-related causes related to erectile function should also be reviewed.
Assessing metabolic syndrome
Metabolic syndrome describes a pattern in which certain cardiometabolic risk factors coexist. In the 2009 common consensus, society-specific waist circumference limit, high triglyceride levels, low HDL levels in men, high blood pressure levels and high fasting glucose levels are evaluated. The presence of at least three of these meets the relevant definition.
Thresholds of 150 mg/dL for triglycerides, less than 40 mg/dL for HDL in men, 130/85 mmHg for blood pressure, and 100 mg/dL for fasting glucose are used. Receiving treatment may also meet the relevant component. However, these values do not replace all diagnostic criteria of other diseases. For example, 130/85 does not describe all classifications of hypertension.
Metabolic syndrome is not a diagnosis of erectile dysfunction or testosterone deficiency per se. The clinical goal is to manage common risks.
Obesity and low testosterone
Obesity reduces SHBG levels in some men. As a result, while total testosterone may be measured low, free testosterone may not be affected to the same extent. In some patients, functional hypogonadism affecting the hypothalamus-pituitary-testicular axis may develop.
For this reason, replacement should not be started in a man with obesity based solely on low total testosterone. Symptoms, appropriate timely repeated measurements, and evaluation of SHBG and free testosterone when necessary are important.
The EAU guideline prioritizes weight management and addressing comorbidities in obesity-related functional hypogonadism. Testosterone replacement is not a weight loss or metabolic rejuvenation treatment. It may also suppress sperm production.
What studies of weight change found
In the 2004 randomised study by Esposito et al., 110 men with obesity and erectile dysfunction were evaluated. The rate of those reaching a normal erectile function score at the end of two years in the structured lifestyle group was reported as 17/55 (31%), and in the control group, 3/55 (5%).
These results indicate that weight loss and physical activity may be beneficial in a specific group. The same rate is not expected for all patients. The study includes a limited number of men in a certain age group. Additional treatments may be required in patients with advanced nerve or vascular damage due to diabetes.
Nutrition, regular physical activity, smoking cessation, and appropriate management of blood sugar, blood pressure, and lipids are beneficial for cardiometabolic health. However, not every lifestyle intervention completely cures erectile dysfunction.
When HOMA-IR is useful
HOMA-IR is a model that tries to predict insulin resistance through fasting insulin and glucose. It is frequently used in research. However, there is no single diagnostic threshold valid in all societies, age groups and laboratories.
HOMA-IR is not a diabetes diagnostic test. Fasting plasma glucose, HbA1c and, when necessary, glucose tolerance test are used in the evaluation of prediabetes and diabetes. Laboratory selection should be made according to the individual’s clinical condition.
The HOMA-IR result or waist circumference measurement is not a validated longevity test that determines overall biological age in years.
What changes visible penile length
The increase in fat tissue in the suprapubic area may reduce the externally visible part of the penis, although its anatomical length does not change. This is not the same mechanism as hardness of erection.
Weight loss may increase apparent length in some individuals, but the result depends on anatomical features. If there are significant buried penis or other anatomical problems, weight loss alone may not be sufficient. Treatment selection should be determined according to examination findings.
Common questions
Does insulin resistance cause erection problems?
It may be associated with vascular and metabolic risks. However, not every erection problem is caused by insulin resistance.
Does a man with a waist circumference of 100 cm have diabetes?
Waist circumference alone is not a diagnosis of diabetes. Glucose metabolism is evaluated with appropriate tests.
Does testosterone increase when you lose weight?
An increase in obesity-related functional hypogonadism may be observed in some men. The result is not the same for everyone.
Is metformin an erectile dysfunction drug?
No. It is used to regulate glucose metabolism in appropriate indications. It is not a direct standard erectile dysfunction treatment.
We have discussed in separate guides why cardiovascular risk is questioned in erectile dysfunction and how testosterone deficiency is confirmed after a low measurement.
Related reading
Metabolic and sexual symptoms require individual clinical evaluation.